Compare PRM & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRM | OCUL |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.4B |
| IPO Year | N/A | 2014 |
| Metric | PRM | OCUL |
|---|---|---|
| Price | $28.19 | $12.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $25.00 | $22.56 |
| AVG Volume (30 Days) | 1.0M | ★ 4.1M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | ★ $636,343,000.00 | $55,783,000.00 |
| Revenue This Year | $15.76 | N/A |
| Revenue Next Year | $5.57 | $14.88 |
| P/E Ratio | $54.16 | ★ N/A |
| Revenue Growth | ★ 19.12 | N/A |
| 52 Week Low | $8.76 | $5.79 |
| 52 Week High | $29.78 | $16.44 |
| Indicator | PRM | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 60.61 | 45.98 |
| Support Level | $26.92 | $11.15 |
| Resistance Level | $28.52 | $14.64 |
| Average True Range (ATR) | 0.98 | 0.90 |
| MACD | -0.21 | -0.15 |
| Stochastic Oscillator | 44.42 | 26.44 |
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.